![The Lotus Valve: REPRISE III Data and Beyond](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/inline-images/BSC_web%20banners_1040x150_03%20%281%29.jpg)
AGENDA
The REPRISE III Pivotal IDE Trial with the Lotus Valve: An Investigator’s Insight
Ted Feldman, MD
Discussion
REPRISE III Secondary Endpoints in Perspective and the Path Ahead for the Lotus Valve
Michael Reardon, MD
Discussion: The Complementary Use of Multiple TAVI Systems to Optimally Treat the Broadest Population of Aortic Stenosis Patients
Martin Leon, MD, Michael Reardon, MD, & Ted Feldman, MD
2017-05-18T10:20:37Z